Clinical Trial: A Drug Drug Interaction (DDI) Study of Selpercatinib (LY3527723) and Rosuvastatin in Healthy Participants
Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Condition: Healthy
Study Type: INTERVENTIONAL
Official Title: Phase 1, Open-Label, Drug Interaction Study to Investigate the Effect of Single Dose Selpercatinib on the Pharmacokinetics of Rosuvastatin in Healthy Participants
Brief Summary:
The main purpose of this study is to determine the effect of selpercatinib on the levels of rosuvastatin in the blood stream in healthy participants.This study will also evaluate the safety and tolerability of rosuvastatin when administered in combination with selpercatinib in healthy participants.This study will last up to approximately 26 days excluding screening period.
Read more